Steve Zenker; Vice President of Investor Relations; Medifast Inc. Daniel Chard; Chairman of the Board, Chief Executive Officer; Medifast Inc. James Maloney; Chief Fi ...

Discover how Medifast navigates GLP-1 market shifts with innovative products like OPTAVIA ASCEND, cost-saving initiatives, and growth strategies for 2025.

Medifast has a 52-week low of $14.76 and a 52-week high of $52.96. The company has a quick ratio of 2.55, a current ratio of 3.11 and a debt-to-equity ratio of 0.06. The company’s 50-day simple ...

I'm sure Tyler will lose the race lead tomorrow, but later in the week I think he'll be contesting ... Johnny Sundt (Kelly Benefits Strategies-Medifast) decided to try and bridge up. For the next 20 ...

Full Year 2024 Results Key Financial Results Revenue: US$602.5m (down 44% from FY 2023).

The stock is trading near its 52-week low, reflecting cautious investor sentiment. Medifast's Q4 2024 performance showed resilience in earnings despite a significant revenue decline. The company ...

BALTIMORE (AP) — BALTIMORE (AP) — Medifast Inc. (MED) on Tuesday reported profit of $800,000 in its fourth quarter. On a per-share basis, the Baltimore-based company said it had profit of 7 cents.

Reports Q4 revenue $119M vs. $191M last year. “This past year was a pivotal year for Medifast (MED), as we continued to transform our business ...

The company expects first quarter 2025 revenue to be in the range of $100 million to $120 million and first quarter 2025 EPS to range from a ...